|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 403.73 USD | -1.32% |
|
-1.02% | -3.57% |
| Dec. 03 | CICC Initiates Linde at Outperform With $510 Price Target | MT |
| Dec. 01 | TD Cowen Adjusts Price Target on Linde to $565 From $560, Maintains Buy Rating | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 27.24B | 30.79B | 33.36B | 32.85B | 33B | |||||
Total Revenues | 27.24B | 30.79B | 33.36B | 32.85B | 33B | |||||
Cost of Goods Sold, Total | 15.38B | 17.54B | 19.45B | 17.49B | 17.14B | |||||
Gross Profit | 11.86B | 13.25B | 13.91B | 15.36B | 15.86B | |||||
Selling General & Admin Expenses, Total | 3.02B | 3B | 2.87B | 3.13B | 3.15B | |||||
R&D Expenses | 152M | 143M | 143M | 146M | 150M | |||||
Depreciation & Amortization - (IS) | 4.63B | 4.64B | 4.2B | 3.82B | 3.78B | |||||
Other Operating Expenses | -40M | -26M | 40M | -10M | -104M | |||||
Other Operating Expenses, Total | 7.75B | 7.75B | 7.26B | 7.08B | 6.97B | |||||
Operating Income | 4.11B | 5.5B | 6.66B | 8.28B | 8.89B | |||||
Interest Expense, Total | -239M | -170M | -215M | -413M | -487M | |||||
Interest And Investment Income | 55M | 40M | 117M | 197M | 228M | |||||
Net Interest Expenses | -184M | -130M | -98M | -216M | -259M | |||||
Income (Loss) On Equity Invest. | 95M | 132M | 190M | 169M | 173M | |||||
Currency Exchange Gains (Loss) | -28M | -29M | -18M | -47M | -11M | |||||
Other Non Operating Income (Expenses) | 85M | 53M | 35M | 16M | 3M | |||||
EBT, Excl. Unusual Items | 4.07B | 5.53B | 6.77B | 8.2B | 8.8B | |||||
Restructuring Charges | -396M | -343M | -78M | -52M | -204M | |||||
Merger & Related Restructuring Charges | -115M | 13M | -74M | - | - | |||||
Gain (Loss) On Sale Of Investments | - | 52M | - | - | - | |||||
Gain (Loss) On Sale Of Assets | -78M | -31M | -9M | 6M | 103M | |||||
Insurance Settlements | - | - | - | - | 45M | |||||
Other Unusual Items | -16M | - | -890M | - | - | |||||
EBT, Incl. Unusual Items | 3.47B | 5.22B | 5.72B | 8.16B | 8.74B | |||||
Income Tax Expense | 847M | 1.26B | 1.43B | 1.81B | 2B | |||||
Earnings From Continuing Operations | 2.62B | 3.96B | 4.28B | 6.34B | 6.74B | |||||
Earnings Of Discontinued Operations | 4M | 5M | - | - | - | |||||
Net Income to Company | 2.63B | 3.96B | 4.28B | 6.34B | 6.74B | |||||
Minority Interest | -125M | -135M | -134M | -142M | -172M | |||||
Net Income - (IS) | 2.5B | 3.83B | 4.15B | 6.2B | 6.56B | |||||
Net Income to Common Incl Extra Items | 2.5B | 3.83B | 4.15B | 6.2B | 6.56B | |||||
Net Income to Common Excl. Extra Items | 2.5B | 3.82B | 4.15B | 6.2B | 6.56B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 4.75 | 7.4 | 8.3 | 12.7 | 13.71 | |||||
Basic EPS - Continuing Operations | 4.74 | 7.39 | 8.3 | 12.7 | 13.71 | |||||
Basic Weighted Average Shares Outstanding | 527M | 517M | 500M | 488M | 479M | |||||
Net EPS - Diluted | 4.71 | 7.33 | 8.23 | 12.59 | 13.62 | |||||
Diluted EPS - Continuing Operations | 4.7 | 7.32 | 8.23 | 12.59 | 13.62 | |||||
Diluted Weighted Average Shares Outstanding | 531M | 522M | 504M | 492M | 482M | |||||
Normalized Basic EPS | 4.6 | 6.42 | 8.19 | 10.21 | 11.12 | |||||
Normalized Diluted EPS | 4.56 | 6.36 | 8.12 | 10.12 | 11.05 | |||||
Dividend Per Share | 3.85 | 4.24 | 4.68 | 5.1 | 5.56 | |||||
Payout Ratio | 81.09 | 57.21 | 56.52 | 40.04 | 40.44 | |||||
Supplemental Items | ||||||||||
EBITDA | 8.73B | 10.14B | 10.86B | 12.1B | 12.67B | |||||
EBITA | 4.87B | 6.22B | 7.23B | 8.83B | 9.44B | |||||
EBIT | 4.11B | 5.5B | 6.66B | 8.28B | 8.89B | |||||
EBITDAR | - | 10.45B | 11.14B | 12.38B | 12.97B | |||||
Effective Tax Rate - (Ratio) | 24.42 | 24.19 | 25.09 | 22.24 | 22.91 | |||||
Current Domestic Taxes | - | - | - | 407M | 610M | |||||
Current Foreign Taxes | - | - | - | 1.49B | 1.53B | |||||
Total Current Taxes | 1.22B | 1.52B | 1.82B | 1.9B | 2.14B | |||||
Deferred Domestic Taxes | - | - | - | 62M | 14M | |||||
Deferred Foreign Taxes | - | - | - | -146M | -156M | |||||
Total Deferred Taxes | -368M | -254M | -383M | -84M | -142M | |||||
Normalized Net Income | 2.42B | 3.32B | 4.09B | 4.98B | 5.32B | |||||
Interest Capitalized | 38M | 57M | 62M | 67M | 68M | |||||
Non-Cash Pension Expense | -178M | -190M | -237M | -164M | -190M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 152M | 143M | 143M | 146M | 150M | |||||
Net Rental Expense, Total | - | 317M | 284M | 284M | 303M | |||||
Imputed Operating Lease Interest Expense | - | 35.49M | 37.01M | 55.77M | 62.68M | |||||
Imputed Operating Lease Depreciation | - | 282M | 247M | 228M | 240M | |||||
Stock-Based Comp., Other (Total) | 133M | 128M | 107M | 141M | 160M | |||||
Total Stock-Based Compensation | 133M | 128M | 107M | 141M | 160M |
- Stock Market
- Equities
- LIN Stock
- Financials Linde plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















